metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Spleen stiffness can be employed to assess the efficacy of spontaneous portosyst...
Journal Information
Vol. 19. Issue 6.
Pages 691-693 (November - December 2020)
Share
Share
Download PDF
More article options
Visits
1269
Vol. 19. Issue 6.
Pages 691-693 (November - December 2020)
Brief Report
Open Access
Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension
Visits
1269
Mauro Giuffrèa,b,
Corresponding author
gff.mauro@gmail.com

Corresponding author at: Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste, Strada di Fiume, 447, 34149 Trieste (TS), Italy.
, Giorgio Bedognib, Cristiana Abaziac, Flora Masuttic, Claudio Tiribellib, Lory Saveria Crocèa,b,c
a Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy
b Italian Liver Foundation, Basovizza (Trieste), Italy
c Liver Clinic, Azienda Sanitaria Universitaria Giuliano-Isontina, Cattinara Hospital, Trieste, Italy
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract
Introduction

Spleen stiffness (SS) has been found to mirror dynamic changes in portal pressure after transjugular intrahepatic portosystemic shunt (TIPS) placement. However, there is no data available regarding SS in patients with spontaneous portosystemic shunting (SPSS), especially in regards to prediction of hepatic decompensation.

Methods

We retrospectively selected patients with confirmed SPSS and esophageal varices (EVs) at endoscopic examination, and recorded any decompensating event (i.e., variceal hemorrhage, overt hepatic encephalopathy, refractory ascites, spontaneous bacterial peritonitis, hepatorenal syndrome) in the first twelve months following liver and spleen elastography.

Results

The patients who presented decompensating events showed lower platelet count (94.5 vs. 121.5 g/L, p < 0.001), higher SS (44 vs. 30 kPa, p < 0.001), higher probability of EVs according to SS (77 vs. 2 %, p < 0.001), and higher spleen diameter (14 vs. 12 cm, p = 0.043). They also showed a higher prevalence of splenorenal shunts (66.7 vs. 31.2%), and a significantly wider SPSS major diameter (14.5 vs. 8 mm, p < 0.001).

Conclusion

SS could predict SPSS efficacy in relieving portal pressure, and could predict decompensating events in patients with SPSS.

Full Text
1Introduction

Portal Hypertension (PH), defined as a portal pressure >10−12 mmHg, is a common and critical complication of liver cirrhosis, which defines the transition to a stage of liver disease characterized by a significant reduced life expectancy and quality of life. [1] Generally, PH is associated with increased risk of esophageal varices, (EVs) and decompensating events (such as ascites, variceal haemorrhage, and hepatic encephalopathy) [2]. Therefore, appropriate PH quantification is crucial and spleen elastography seems to address this unmet clinical need. Despite its proven correlation with the invasive gold standard of hepatic venous pressure gradient (HVPG) [3], spleen stiffness (SS) has been found to mirror dynamic changes in portal pressure after transjugular intrahepatic portosystemic shunt (TIPS) placement [4,5].

This led us to investigate the role of SS in the paraphysiological version of TIPS (i.e., spontaneous portosystemic shunts, SPSS). In particular, we aimed to determine if SS could have predicted the efficacy of SPSS in relieving portal pressure, especially considering the fact that a group of patients with esophageal varices (EVs) and without current non-selective beta-blockers (NSBB) administration were not correctly classified by the spleen stiffness probability index, a mathematical device that we had previously developed in a sample of 210 cirrhotic patients [6]. In detail, this index provides a given probability of having EVs based on the individual value of SS, which could also be employed as a non-invasive surrogate of clinically significant portal hypertension (CSPH). Surprisingly, in this group of patients the SS was either low or comparable to those of healthy individuals [7,8] despite the presence of EVs at endoscopy. Of notice all presented SPSS.

2Methods

Spleen and Liver Stiffness as well as the laboratory tests reported in Table 1 were performed, as per the standard clinical practice, on patients who were evaluated by the Liver Clinic between January 2018 and December 2018. The methodology behind elastography measurement was already explained in detail elsewhere [6,8,9].

Table 1.

Patients were stratified in two groups according to the development of decompensating events in two groups. Variable are presented as absolute number (relative percentage) or median (Quartile 1;Quartile 3). Intergroup differences were assessed trough Mann-Whitney U test for numerical variables and Chi-Square Test for ordinal variable. SPSS: spontaneous portosystemic shunt; AST (aspartate aminotransferase); ALT (alanine aminotransferase); ALP (alkaline phosphatase); LS (liver stiffness); SS (spleen stiffness); EVs (esophageal varices).

  Totaln = 52  Patients withoutDecompensating Eventsn = 22  Patients withDecompensatingEventsN = 30  Significance 
Gender, Male(%)  30 (57.7)  14 (63.6)  16 (53.3)  NS 
Age, years  65 (62;68)  65.5 (63;69)  64.5 (62;67)  NS 
Etiology, N(%)AlcoholAbuseViralHepatitis  29 (55.8)23 (44.2)  15 (68.2)7 (31.8)  14 (46.7)16 (53.3)   
Type of SPSS,N (%)ParaumbilicalSplenorenal  25 (48.1)27 (51.9)  15 (68.2)7 (31.2)  10 (33.3)20 (66.7)  P = 0.013Cramer's Phi = 0.345 
AST (IU/L)  27 (23;29.5)  28.5 (24.25;31.75)  26 (23;28.75)  NS 
ALT (IU/L)  22 (20;24)  21.5 (19.25;23.5)  22 (20;30.75)  NS 
GGT (IU/L)  27 (26;39)  27 (23.75;36.75)  27.5 (26;39)  NS 
ALP (IU/L)  82 (80;91)  81.5 (80;90)  82 (80; 97.75)  NS 
Total Bilirubin(mg/dL)  2 (1.75;2.20)  1.95 (1.60; 2.20)  2.04 (1.70; 2.32)  NS 
Albumin(g/dL)  3.2 (2.9;3.4)  3.4 (3;3.6)  3.3 (2.9;3.6)  NS 
Platelet (g/L)  110 (92.75;121)  121.5 (115.75;123.75)  94.5 (78.25;100)  P < 0.001 
LS (kPa)  42 (40;46)  40.5 (32.5;43)  45 (40.25;47.75)  p = 0.003 
Probability ofEVs accordingto LS (%)  74 (73;75)  73 (69;74)  75 (74;77)  P = 0.006 
SS (kPa)  39.5 (30;45)  30 (26.5;32.75)  44 (41.25;55)  p < 0.001 
Probability ofEVs accordingto SS (%)  56 (4;81)  2 (0.5;11)  77 (66;94)  p < 0.001 
SPSSDiameter(mm)  8 (11;16)  8 (7;10)  14.5 (10.25;19)  p < 0.001 
SpleenDiameter (cm)  13 (12;15)  12 (12;14)  14 (12;16)  p = 0.043 

We retrospectively selected patients with confirmed SPSS and EVs at endoscopic examination, and recorded any decompensating event (i.e., variceal hemorrhage, overt hepatic encephalopathy, refractory ascites, spontaneous bacterial peritonitis, hepatorenal syndrome) in the first twelve months following elastography examination.

3Results

Patients were stratified in two groups based on the development of decompensating events; their characteristics are reported in Table 1. Patients were predominantly male (57.5%), with a median age of 65 (62; 68) years. The etiology of liver disease was alcohol abuse in 55.8% of patients and virus-related in 44.2% of patients. The patients who presented decompensating events showed lower platelet count (94.5 vs. 121.5 g/L, p < 0.001), higher SS (44 vs. 30 kPa, p < 0.001), higher probability of EVs according to SS (77 vs. 2%, p < 0.001), and higher spleen diameter (14 vs. 12 cm, p = 0.043). They also showed a higher prevalence of splenorenal shunts (66.7 vs. 31.2%), and a significantly wider SPSS major diameter (14.5 vs. 8 mm, p < 0.001).

4Discussion

The importance of these findings resides in the fact that SPSS can be interpreted as a physiological attempt of the human body to decompress the portal venous system. Unfortunately, SPSS often does not allow adequate reduction of portal pressure, which can present elevated value despite the presence of massive SPSS [10]. What if we could employ a simple and non-invasive method to check if SPSS are effectively accomplishing their purpose of reducing the portal pressure? The answer to this question yields high relevance (given the fact that SPSS are relatively common in liver cirrhosis and that the clinical evolution of cirrhotic patients is extremely variable) and could find a possible answer in SS, especially because SS has already been reported to predict hepatic decompensation [11].

These results, albeit interesting, must be taken with caution due to the relatively low numerosity of the sample size and the possible limitations related to selection bias. While waiting for the essential external validation, we strongly believe that SS may be valuable in the everyday clinical evaluation of cirrhotic patients.

Authors’ contributions

M.G., G.B., C.A., F.M., C.T. and L.S.C. were involved in the conceptualization and supervision of the current work. M.G., C.A., F.M., L.S.C. were involved in patients’ investigation and data collection. M.G. and L.S.C. performed formal statistical analysis. M.G., G.B., C.A., F.M., C.T. and L.S.C. were involved in the writing the original draft and approving the final version of the manuscript.

Funding statement

The authors received no specific funding for this work.

Conflict of interest

The authors have no conflicts of interest to declare.

References
[1]
G. D’Amico, G. Garcia-Tsao, L. Pagliaro.
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
J Hepatol, 44 (2006), pp. 217-231
[2]
North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices.
Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices.
N Engl J Med, 319 (1988), pp. 983-989
[3]
F. Ravaioli, A. Colecchia, E. Dajti, G. Marasco, L.V. Alemanni, M. Tamè, et al.
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients.
World J Hepatol, 27 (2018), pp. 731-742
[4]
M. Buechter, P. Manka, J.M. Theysohn, M. Reinboldt, A. Canbay, A. Kahraman.
Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation.
Dig Liver Dis, 50 (2018), pp. 54-60
[5]
H.-T. Ran, X.-P. Ye, Y.-Y. Zheng, D.-Z. Zhang, Z.-G. Wang, J. Chen, et al.
Spleen stiffness and splenoportal venous flow: assessment before and after transjugular intrahepatic portosystemic shunt placement.
J Ultrasound Med, 32 (2013), pp. 221-228
[6]
M. Giuffrè, D. Macor, F. Masutti, C. Abazia, F. Tinè, G. Bedogni, et al.
Spleen Stiffness Probability Index (SSPI): a simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis.
Ann Hepatol, 19 (2020), pp. 53-61
[7]
M. Giuffrè, D. Macor, F. Masutti, C. Abazia, F. Tinè, R. Patti, et al.
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography.
Ann Hepatol, 18 (2019), pp. 736-741
[8]
M. Giuffrè, S. Fouraki, M. Campigotto, A. Colombo, A. Visintin, M.R. Buonocore, et al.
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis.
[9]
M. Giuffrè, S. Fouraki, M. Comar, F. Masutti, L.S. Crocè.
The importance of transaminases flare in liver elastography: characterization of the probability of liver fibrosis overestimation by hepatitis C virus-induced cytolysis.
[10]
J.S. Hsieh, J.Y. Wang, C.J. Huang, F.-M. Chen, T.-J. Huang.
Effect of spontaneous portosystemic shunts on hemorrhage from esophagogastric varices.
World J Surg, 28 (2004), pp. 23-28
[11]
P. Meister, A. Dechêne, M. Büchter, Julia Kälsch, G. Gerken, A. Canbay, et al.
Spleen stiffness differentiates between acute and chronic liver damage and predicts hepatic decompensation.
J Clin Gastroenterol, 53 (2019), pp. 457-463
Copyright © 2020. Fundación Clínica Médica Sur, A.C.
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos